Close

Lazard Capital Starts Vanda Pharmaceuticals (VNDA) at Buy

February 5, 2013 6:35 AM EST Send to a Friend
Lazard Capital initiates coverage on Vanda Pharmaceuticals (NASDAQ: VNDA) with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login